Cargando…

Rare variants in the ATM gene and risk of breast cancer

INTRODUCTION: The ataxia-telangiectasia mutated (ATM) gene (MIM ID 208900) encodes a protein kinase that plays a significant role in the activation of cellular responses to DNA double-strand breaks through subsequent phosphorylation of central players in the DNA damage-response pathway. Recent studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldgar, David E, Healey, Sue, Dowty, James G, Da Silva, Leonard, Chen, Xiaoqing, Spurdle, Amanda B, Terry, Mary Beth, Daly, Mary J, Buys, Saundra M, Southey, Melissa C, Andrulis, Irene, John, Esther M, Khanna, Kum Kum, Hopper, John L, Oefner, Peter J, Lakhani, Sunil, Chenevix-Trench, Georgia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236337/ https://www.ncbi.nlm.nih.gov/pubmed/21787400 http://dx.doi.org/10.1186/bcr2919

Ejemplares similares

No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer
por: Spurdle, Amanda B, et al.
Publicado: (2002)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab
por: Li, Hongyan, et al.
Publicado: (2016)

A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families
por: Choi, Yun-Hee, et al.
Publicado: (2021)

Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)
por: Terry, Mary Beth, et al.
Publicado: (2016)

BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2007)

Correction: BCoR-L1 variation and breast cancer
por: Lose, Felicity, et al.
Publicado: (2008)

High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations
por: Johnston, Rebecca L., et al.
Publicado: (2016)

ATM mediated phosphorylation of CHD4 contributes to genome maintenance
por: Urquhart, Aaron J, et al.
Publicado: (2011)

A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy
por: Liu, Chao, et al.
Publicado: (2014)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer
por: Al-Ejeh, Fares, et al.
Publicado: (2014)

Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry
por: Smith, Letitia D, et al.
Publicado: (2011)

Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
por: Terry, Mary Beth, et al.
Publicado: (2018)

Inactivation of ATM/ATR DNA Damage Checkpoint Promotes Androgen Induced Chromosomal Instability in Prostate Epithelial Cells
por: Chiu, Yung-Tuen, et al.
Publicado: (2012)

Population-based estimates of age-specific cumulative risk of breast cancer for pathogenic variants in ATM
por: Renault, Anne-Laure, et al.
Publicado: (2022)

Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
por: Momeny, Majid, et al.
Publicado: (2015)

Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
por: Lovelock, Paul K, et al.
Publicado: (2007)

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
por: Chang, Jiun-Horng, et al.
Publicado: (2005)

Non-invasive optical spectroscopic monitoring of breast development during puberty
por: Lilge, Lothar, et al.
Publicado: (2017)

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool
por: Phillips, Kelly-Anne, et al.
Publicado: (2019)

Women's thoughts on receiving and sharing genetic information: Considerations for genetic counseling
por: Pfledderer, Christopher D., et al.
Publicado: (2022)

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib
por: Bessette, Darrell C., et al.
Publicado: (2015)

Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer
por: Houghton, Lauren C., et al.
Publicado: (2018)

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Spurdle, Amanda B, et al.
Publicado: (2005)

Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)
por: Hopper, John L., et al.
Publicado: (2018)

Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)
por: Zeinomar, Nur, et al.
Publicado: (2019)

Pubertal development in girls by breast cancer family history: the LEGACY girls cohort
por: Terry, Mary Beth, et al.
Publicado: (2017)

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
por: Byrnes, Graham B, et al.
Publicado: (2008)

Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC)
por: Ye, Zhoufeng, et al.
Publicado: (2022)

Identification of new breast cancer predisposition genes via whole exome sequencing
por: Southey, MC, et al.
Publicado: (2012)

The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia
por: Marsh, Anna, et al.
Publicado: (2001)

Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer
por: Houghton, Lauren C., et al.
Publicado: (2019)

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer
por: Da Silva, Leonard, et al.
Publicado: (2010)

Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
por: Kehm, Rebecca D., et al.
Publicado: (2019)

Variation in the RAD51 gene and familial breast cancer
por: Lose, Felicity, et al.
Publicado: (2006)

ATM-dependent phosphorylation of MRE11 controls extent of resection during homology directed repair by signalling through Exonuclease 1
por: Kijas, Amanda W., et al.
Publicado: (2015)

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
por: Chenevix-Trench, Georgia, et al.
Publicado: (2007)

Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk
por: Kehm, Rebecca D, et al.
Publicado: (2021)

BRCA1 A-Complex fine tunes repair functions of BRCA1
por: Harris, Janelle L, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4b9gfg64akojj9qgm5p8shjns7